Holen Sie sich die Stockscreener-App
4.17
4.68%
-0.21
Schlusskurs vom Vortag:
$4.38
Offen:
$4.38
24-Stunden-Volumen:
165.73K
Relative Volume:
0.80
Marktkapitalisierung:
$235.46M
Einnahmen:
$2.76M
Nettoeinkommen (Verlust:
$-49.12M
KGV:
-2.78
EPS:
-1.5
Netto-Cashflow:
$-46.21M
1W Leistung:
-3.36%
1M Leistung:
+9.01%
6M Leistung:
+62.45%
1J Leistung:
+8.72%
1-Tages-Spanne:
$4.13
$4.45
1-Wochen-Bereich:
$4.13
$4.89
52-Wochen-Spanne:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.17 | 247.32M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.57 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.28 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.71 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.76 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.67 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Eingeleitet | TD Cowen | Buy |
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Chardan reiterates Orchestra BioMed stock rating on trial focus - Investing.com UK
Orchestra BioMed Holdings, Inc. (OBIO) Exceeds Expectations for Q4 Earnings and Revenue - Bitget
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - Investing News Network
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Orchestra BioMed Holdings 10-K Summary — Revenue: $— | EPS: $— - TradingView
Aug Analyst Calls: Will Orchestra BioMed Holdings Inc benefit from AI trendsTrade Risk Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Why Orchestra BioMed Holdings Inc. stock could outperform in 2026Portfolio Update Report & Risk Managed Trade Strategies - Naître et grandir
Insider Sell: How resilient is Orchestra BioMed Holdings Inc. stock in market downturns2025 Key Highlights & Verified Short-Term Trading Plans - Naître et grandir
Market Leaders: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Orchestra BioMed to present hypertension therapy data at medical meetings By Investing.com - Investing.com Canada
Orchestra BioMed announces presentations highlighting Avim therapy potential impact on hypertensive heart disease and heart failure at THT and CRT - marketscreener.com
Orchestra BioMed to present hypertension therapy data at medical meetings - Investing.com
Orchestra BioMed Announces Presentations Highlighting AVIM - GlobeNewswire
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT - 富途牛牛
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
OBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
RTW INVESTMENTS, LP Increases Stake in Orchestra BioMed Holdings Inc - GuruFocus
Medtronic (OBIO) affiliates hold 17.8% of Orchestra BioMed in amended 13G/A - Stock Titan
Earnings Beat: How much upside does Orchestra BioMed Holdings Inc have2025 Fundamental Recap & Accurate Technical Buy Alerts - baoquankhu1.vn
Orchestra BioMed to Present at Two Healthcare Conferences - MyChesCo
Gains Report: Is Tuya Inc Depositary Receipt a play on infrastructure spending - baoquankhu1.vn
OBIOOrchestra BioMed Holdings Inc Latest Stock News & Market Updates - Stock Titan
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Orchestra BioMed Holdings (OBIO) and Teladoc (TDOC) - The Globe and Mail
Will Orchestra BioMed Holdings Inc. benefit from geopolitical trendsJuly 2025 Decliners & Real-Time Volume Analysis Alerts - mfd.ru
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewswire
Orchestra BioMed (NASDAQ:OBIO) Trading 4.2% HigherHere's What Happened - MarketBeat
Orchestra BioMed Grants Inducement Stock Options to Nine New Employees - MyChesCo
Earnings Recap: Will MITTPRA stock hit new highs in YEARQuarterly Earnings Report & Expert Approved Trade Ideas - baoquankhu1.vn
Orchestra BioMed announces inducement grants - Medical Buyer
What is Orchestra BioMed Holdings Inc. s P E ratio telling usJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan - TipRanks
Orchestra BioMed Grants Stock Options to New Employees as Part of 2025 Inducement Plan - Quiver Quantitative
Does Orchestra BioMed Holdings Inc. outperform in volatile markets2025 Price Targets & Growth Focused Investment Plans - mfd.ru
Targets Report: How Orchestra BioMed Holdings Inc. stock performs after earningsJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
How sensitive is Orchestra BioMed Holdings Inc. to inflation2025 Trade Ideas & Fast Exit/Entry Strategy Plans - mfd.ru
MACD Signal: What is Orchestra BioMed Holdings Incs 5 year growth outlookEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail
Short Covering: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Year in Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Guidance Update: Does Orchestra BioMed Holdings Inc stock benefit from AI growth2025 Winners & Losers & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Risk Report: Is Rafael Holdings Inc affected by consumer sentimentShare Buyback & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% - Yahoo Finance
Aug Setups: What is Orchestra BioMed Holdings Inc. s 5 year growth outlookWeekly Trading Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Orchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 Meeting - MSN
AMH Equity Ltd Buys New Position in Orchestra BioMed Holdings, Inc. $OBIO - Defense World
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Retail Trends: Does PNTG have strong fundamentalsQuarterly Trade Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Support Test: Is Orchestra BioMed Holdings Inc stock a contrarian buyQuarterly Performance Summary & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Retail Trends: Should value investors consider Orchestra BioMed Holdings Inc - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Acquisition of Vivasure Boosts Orchestra BioMed's Finances - GuruFocus
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):